Armata Pharmaceuticals (ARMP) Equity Ratio (2016 - 2018)
Armata Pharmaceuticals (ARMP) has disclosed Equity Ratio for 6 consecutive years, with 0.83 as the latest value for Q3 2018.
- Quarterly Equity Ratio rose 16.99% to 0.83 in Q3 2018 from the year-ago period, while the trailing twelve-month figure was 0.83 through Sep 2018, up 16.99% year-over-year, with the annual reading at 2.19 for FY2017, 308.05% up from the prior year.
- Equity Ratio hit 0.83 in Q3 2018 for Armata Pharmaceuticals, down from 0.99 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 2.19 in Q4 2017 to a low of 0.91 in Q1 2014.
- Historically, Equity Ratio has averaged 0.48 across 5 years, with a median of 0.46 in 2017.
- Biggest five-year swings in Equity Ratio: skyrocketed 495.1% in 2016 and later decreased 11.04% in 2017.
- Year by year, Equity Ratio stood at 0.12 in 2014, then skyrocketed by 236.13% to 0.4 in 2015, then soared by 32.67% to 0.54 in 2016, then surged by 308.05% to 2.19 in 2017, then plummeted by 62.1% to 0.83 in 2018.
- Business Quant data shows Equity Ratio for ARMP at 0.83 in Q3 2018, 0.99 in Q2 2018, and 1.02 in Q1 2018.